 |
PHARMACEUTICAL INDUSTRY :
Organizational Transformation |
|
| |
Client: |
|
A
major global pharmaceutical manufacturer with a strong biopharmaceutical
presence. |
| |
|
|
|
| |
Problem: |
|
U.S.
biopharmaceutical division plagued by supply issues, process inefficiencies
(including declining yield) and low morale. There was corporate concern
regarding division's ability to meet production needs to support launch
of new 'blockbuster' product. |
| |
|
|
|
| |
Approach: |
|
A broad assessment was conducted to evaluate organizational structure,
behaviors, leadership and management systems, manufacturing process
capabilities and quality systems. The assessment led to the implementation
of a comprehensive operational improvement program employing integrated
Six-Sigma/SPC and OD approaches focused on improving the technical,
compliance, and personal skills performance of organization. |
| |
|
|
|
| |
Results: |
|
An
effective transformation of the division was achieved within 9 months,
including:
Doubling of production capacity
10% - 20% increase in production efficiency (yield)
50% reduction in batch record review cycle time
$2M in specific cost savings
Higher production reliability/product consistency
Improved management and control of operations through the introduction
of a multi-level metrics (monitoring) program
Improved management and staff competency to support sustained
performance and launch of new blockbuster product
Improved morale
Successful FDA Inspection (PAI) for new blockbuster product
10-Fold ROI for client
Click here to view chart
See full BioPharm magazine article
|
| |
|
|
|
| |
 |
|
|
| |
|
|
|